Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000947871-25-000572·GMS Ventures & Investments
Schedule 13D ownership disclosure
OUTLOOK THERAPEUTICS INC
Common Stock, par value $0.01 per share · CUSIP: 69012T305
Event date: 2025-05-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- GMS VENTURES & INVESTMENTSReported CIK 0001804598
Shares: 29,040,929.00 · Class: 50.3%
- SUKHTIAN GHIATH M.Reported CIK 0001717441
Shares: 29,040,929.00 · Class: 50.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-25-000572
- Form type
- SCHEDULE 13D/A
- Filer
- GMS Ventures & Investments
- CIK
- CIK 1804598
- Filed
- May 28, 2025
- Reporting period
- May 27, 2025
- Description
- Schedule 13D beneficial ownership